Filippo Alongi
Filippo Alongi
Direttore Radioterapia Oncologica, Ospedale Sacro Cuore, Negrar (Verona)
Adresse e-mail validée de
Citée par
Citée par
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial
M Scorsetti, S Arcangeli, A Tozzi, T Comito, F Alongi, P Navarria, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 336-342, 2013
Review and uses of stereotactic body radiation therapy for oligometastases
F Alongi, S Arcangeli, AR Filippi, U Ricardi, M Scorsetti
The oncologist 17 (8), 1100, 2012
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non …
P Navarria, AM Ascolese, P Mancosu, F Alongi, E Clerici, A Tozzi, C Iftode, ...
Radiotherapy and Oncology 107 (3), 414-418, 2013
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
F Alongi, C Fiorino, C Cozzarini, S Broggi, L Perna, GM Cattaneo, ...
Radiotherapy and Oncology 93 (2), 207-212, 2009
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments
M Scorsetti, F Alongi, S Castiglioni, A Clivio, A Fogliata, F Lobefalo, ...
Radiation oncology 6 (1), 1-8, 2011
MR-guidance in clinical reality: current treatment challenges and future perspectives
S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ...
Radiation Oncology 14 (1), 1-12, 2019
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
F Alongi, L Cozzi, S Arcangeli, C Iftode, T Comito, E Villa, F Lobefalo, ...
Radiation Oncology 8 (1), 1-8, 2013
Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer
C Cozzarini, C Fiorino, N Di Muzio, F Alongi, S Broggi, M Cattaneo, ...
Radiotherapy and oncology 84 (2), 164-170, 2007
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
L Triggiani, F Alongi, M Buglione, B Detti, R Santoni, A Bruni, ...
British journal of cancer 116 (12), 1520-1525, 2017
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
A Tozzi, T Comito, F Alongi, P Navarria, C Iftode, P Mancosu, G Reggiori, ...
Radiation Oncology 8 (1), 1-8, 2013
Need for high radiation dose (≥ 70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients
C Cozzarini, F Montorsi, C Fiorino, F Alongi, A Bolognesi, LF Da Pozzo, ...
International Journal of Radiation Oncology* Biology* Physics 75 (4), 966-974, 2009
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
P Navarria, AM Ascolese, S Tomatis, L Cozzi, F De Rose, P Mancosu, ...
Radiation Oncology 9 (1), 1-8, 2014
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of …
M Scorsetti, F Alongi, A Fogliata, S Pentimalli, P Navarria, F Lobefalo, ...
Radiation oncology 7 (1), 1-8, 2012
Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy
C Fiorino, N Di Muzio, S Broggi, C Cozzarini, E Maggiulli, F Alongi, ...
International Journal of Radiation Oncology* Biology* Physics 71 (2), 611-617, 2008
Dose–volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer
C Fiorino, F Alongi, L Perna, S Broggi, GM Cattaneo, C Cozzarini, ...
International Journal of Radiation Oncology* Biology* Physics 75 (1), 29-35, 2009
Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients
M Scorsetti, F Alongi, AR Filippi, S Pentimalli, P Navarria, E Clerici, ...
Acta Oncologica 51 (5), 618-623, 2012
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients
C Cozzarini, C Fiorino, LF Da Pozzo, F Alongi, G Berardi, A Bolognesi, ...
International Journal of Radiation Oncology* Biology* Physics 82 (1), 191-199, 2012
Neuroendocrine carcinoma of the breast: current evidence and future perspectives
A Inno, G Bogina, M Turazza, L Bortesi, S Duranti, A Massocco, ...
The oncologist 21 (1), 28, 2016
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique
R Ruggieri, S Naccarato, R Mazzola, F Ricchetti, S Corradini, A Fiorentino, ...
Radiation Oncology 13 (1), 1-9, 2018
Phase I–II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer
N Di Muzio, C Fiorino, C Cozzarini, F Alongi, S Broggi, P Mangili, ...
International Journal of Radiation Oncology* Biology* Physics 74 (2), 392-398, 2009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20